NASDAQ:CAPR

Capricor Therapeutics Stock Predictions

Healthcare > Biotechnology

Invest in CAPR

$10.86

-0.260 (-2.34%)

At Close: May 22, 2025

Currently predicting for Fri, 23 May 2025

Trading levels for CAPR

Full Access. No Commitment. 14 Days Free!

Long & Short-Term Golden Star Lists

AI Stock Analysis Powered by GPT-4o*

Top 5 Candidates on Every List

Premium Lists

Ad-FREE Browsing

Advanced Stock Screener

GET STARTED!

Already have an account? Sign In Here

Fibonacci Support & Resistance Levels

Level	Price
R3	11.40	5.00%
R2	11.20	3.11%
R1	11.07	1.94%
Price	10.86
S1	10.66	-1.84%
S2	10.53	-3.00%
S3	10.33	-4.89%

Accumulated Volume Support & Resistance Levels

Level	Price
R3	13.28	22.28%
R2	11.12	2.39%
R1	11.01	1.38%
Price	10.86
S1	9.56	-11.97%
S2	9.49	-12.62%
S3	9.44	-13.08%

CAPR Predictions History

3 hours ago
PredictionBot.Kathy predicted that CAPR for today is going $10.39 (-4.32%)

3 hours ago
PredictionBot.Warren predicted that CAPR for today is going $10.57 (-2.70%)

12 hours ago
matthewbspeicher predicted that CAPR for today is going

3 weeks ago
PredictionBot.Kathy predicted that CAPR for Apr. 30th is going $12.99 (2.26%)

3 weeks ago
PredictionBot.Warren predicted that CAPR for Apr. 30th is going $12.83 (1.00%)

3 weeks ago
drkholl predicted that CAPR for Apr. 30th is going $18.52 (47.45%)

Rank:

2 months ago
PredictionBot.Kathy predicted that CAPR for Mar. 3rd is going $14.92 (9.12%)

2 months ago
PredictionBot.Warren predicted that CAPR for Mar. 3rd is going $15.09 (10.39%)

2 months ago
dougbiddle07 predicted that CAPR for Mar. 3rd is going $16.65 (8.26%)

Rank:

6 months ago
thedean2010 predicted that CAPR for 2024-11-14 is going

ABOUT CAPRICOR THERAPEUTICS

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Ph...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
UAA $5.84	11.64%	May 09
IIPR $54.61	1.70%	May 09
HBM $7.41	14.44%	May 05
PODD $257.01	24.90%	May 02
GT $9.14	21.77%	Mar 21

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by